Volume 81, Issue 8, Pages (April 2012)

Slides:

Advertisements

Similar presentations

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and.

Advertisements

Volume 88, Issue 5, Pages (November 2015)

New options for the anemia of chronic kidney disease

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Volume 86, Issue 1, Pages (July 2014)

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Prehypertension and chronic kidney disease: the ox or the plow?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

John P. Middleton, Patrick H. Pun Kidney International

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 70, Pages S21-S25 (December 2006)

Chapter 4: Red cell transfusion to treat anemia in CKD

Pure red cell aplasia due to follow-on epoetin

Comorbidity and confounding in end-stage renal disease

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 74, Issue 3, Pages (August 2008)

Punit Yadav, Nelson Leung, Paul W. Sanders, Paul Cockwell

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Volume 70, Issue 11, Pages (December 2006)

Volume 86, Issue 2, Pages (August 2014)

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Volume 87, Issue 2, Pages (February 2015)

Harnessing regulatory T cells for therapeutic purposes

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Bisphosphonate safety and efficacy in chronic kidney disease

Kenar D. Jhaveri, Steven Fishbane Kidney International

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Günter Weiss, Florian Kronenberg Kidney International

Effects of hemodialysis on cardiac function

Francesco Locatelli, Lucia Del Vecchio Kidney International

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 85, Issue 5, Pages (May 2014)

Nephrology Crossword: Peritoneal Dialysis

Methods for guideline development

Old friends form alliance against podocytes

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

A man with a hole in his penis

Vitamin D in chronic kidney disease: is the jury in?

Volume 82, Issue 9, Pages (November 2012)

The treatment of acute interstitial nephritis: More data at last

Volume 83, Issue 5, Pages (May 2013)

Volume 72, Issue 2, Pages (July 2007)

Volume 55, Pages S3-S16 (June 1999)

Volume 80, Issue 10, Pages (November 2011)

Volume 83, Issue 4, Pages (April 2013)

The hypothesis that abnormal BH4 metabolism impairs kidney function

Volume 70, Issue 3, Pages (August 2006)

ANCA comes of age—but with caveats

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 75, Issue 7, Pages (April 2009)

Innovative teaching tools in nephrology

Membranous nephropathy: recent travels and new roads ahead

Hisataka Kobayashi, Peter L. Choyke Kidney International

The international realities of live donor kidney transplantation

Where vaptans do and do not fit in the treatment of hyponatremia

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Volume 74, Issue 10, Pages (November 2008)

Volume 68, Issue 3, Pages (September 2005)

Sugar-sweetened beverages and chronic disease

Presentation transcript:

Volume 81, Issue 8, Pages 727-732 (April 2012) Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights Iain C. Macdougall, Simon D. Roger, Angel de Francisco, David J.A. Goldsmith, Huub Schellekens, Hans Ebbers, Wolfgang Jelkmann, Gérard London, Nicole Casadevall, Walter H. Hörl, David M. Kemeny, Carol Pollock Kidney International Volume 81, Issue 8, Pages 727-732 (April 2012) DOI: 10.1038/ki.2011.500 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Factors involved in the pathogenesis of erythropoiesis-stimulating agent (ESA)–induced pure red cell aplasia (PRCA). Kidney International 2012 81, 727-732DOI: (10.1038/ki.2011.500) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Proposed treatment algorithm for erythropoiesis-stimulating agent (ESA)–induced pure red cell aplasia. Kidney International 2012 81, 727-732DOI: (10.1038/ki.2011.500) Copyright © 2012 International Society of Nephrology Terms and Conditions